Why the study?
Does recombinant factor VIIa affect coronary artery bypass graft patency in patients in the early postoperative period following CABG?
Does recombinant factor VIIa affect coronary artery bypass graft patency in patients in the early postoperative period following CABG?
Answers are grounded in this paper and cite their sources.
This case report and literature review explores coronary artery bypass graft patency following the administration of recombinant factor VIIa in the early postoperative period.
We present our experience of a unique opportunity to survey coronary artery bypass graft (CABG) patency following the administration of recombinant factor VIIa in the early postoperative period. A review of the published literature on use of this medication in cardiothoracic surgery, specifically CABG, is included.
No takes yet. Share an insight, caveat, or question.
Beldowicz et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: